Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Imprint coding on solid medication forms: problems in interpretation.

S C Smolinske1, W O Robertson

  • 1POISINDEX Information System, Micromedex, Inc, Denver, Colorado.

Veterinary and Human Toxicology
|April 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vinegaroon exposures reported to a Poison center.

Toxicon : official journal of the International Society on Toxinology·2022
Same author

Envenomations during pregnancy reported to the national poison data system, 2009-2018.

Toxicon : official journal of the International Society on Toxinology·2020
Same author

Comparison of F(ab')<sub>2</sub> and Fab antivenoms in rattlesnake envenomation: First year's post-marketing experience with F(ab')<sub>2</sub> in New Mexico.

Toxicon : official journal of the International Society on Toxinology·2020
Same author

Unpredicted late-, new-onset thrombocytopenia and hypofibrinogenemia in Fab antivenom-treated rattlesnake envenomation.

Toxicon : official journal of the International Society on Toxinology·2020
Same author

Identification of unidentified tablets and capsules.

Canadian Medical Association journal·2010
Same author

Believe it or not--silver still poisons!

Veterinary and human toxicology·2002
Same journal

V&HT's future--like all futures--remains 'uncertain'.

Veterinary and human toxicology·2004
Same journal

Preparing for an era of weapons of mass destruction (WMD)--are we there yet? Why we should all be concerned. Part II.

Veterinary and human toxicology·2004
Same journal

Melatonin exposures reported to Texas poison centers in 1998-2003.

Veterinary and human toxicology·2004
Same journal

Acute pesticide poisoning related deaths in Turkey.

Veterinary and human toxicology·2004
Same journal

Atypical poisonings with botanicals raise suspicion of malicious activity.

Veterinary and human toxicology·2004
Same journal

Regulation of genetically modified organisms (GMOs) in the European Union: principles of risk assessment.

Veterinary and human toxicology·2004
See all related articles

Medication imprinting accuracy is crucial for patient safety. Current "logotype" identification methods are unreliable, necessitating clearer identifiers and field testing before FDA implementation.

Area of Science:

  • Pharmaceutical Sciences
  • Drug Safety
  • Regulatory Affairs

Background:

  • The U.S. Food and Drug Administration (FDA) is considering mandatory imprinting for all solid oral dosage forms.
  • Accurate and rapid identification of medication manufacturers is essential for preventing medication errors and ensuring patient safety.
  • Current imprinting methods, often relying on 'logotypes,' may not meet necessary accuracy standards.

Purpose of the Study:

  • To evaluate the accuracy and reliability of current medication imprinting systems, specifically 'logotypes'.
  • To advocate for improved medication identification methods to enhance drug safety.
  • To recommend further validation of proposed imprinting systems before widespread implementation.

Main Methods:

  • Analysis of existing data on medication imprinting accuracy.

Related Experiment Videos

  • Assessment of the performance of 'logotype' based identification systems.
  • Review of FDA's proposed imprinting mandate.

    • Main Results:

    • Data indicate that current 'logotype' imprinting methods significantly fall below acceptable accuracy levels for medication identification.
    • The effectiveness and reliability of existing systems are insufficient for ensuring rapid and accurate manufacturer identification.
    • There is a critical need for more precise and universally recognizable medication identifiers.

    Conclusions:

    • Current medication imprinting practices, particularly the use of 'logotypes,' are inadequate for ensuring accurate and timely identification.
    • Clear, unambiguous identifiers are necessary to improve medication safety and prevent counterfeit drugs.
    • Field testing of any new imprinting system is imperative before FDA mandate to ensure its practical efficacy and safety.